cDPP3 and Outcomes in Acute Heart Failure: An Analysis of the STRONG-HF and CORTAHF Studies
In AHF, cDPP3 was mildly elevated and was not associated with clinical outcomes or congestion relief during GDMT optimization. Elevated cDPP3 identified a distinct clinical phenotype but did not confer adverse prognosis.
Authors
- Koji Takagi (ORCID: https://orcid.org/0000-0003-0213-1509)
- Oliver Hartmann (ORCID: https://orcid.org/0000-0002-5663-645X)
- Christopher Edwards (ORCID: https://orcid.org/0000-0003-4908-9758)
- Adrien Picod (ORCID: https://orcid.org/0000-0002-0639-5598)
- Gad Cotter (ORCID: https://orcid.org/0000-0002-9613-3339)
- A Mebazaa
- F Azibani
- B Davison
- K Bourgeois
- J Bruno
- A P Ambrosy
Institutions
- University of Bern (CH)
- Kaiser Permanente (US)
- Inserm (FR)
- Université Sorbonne Nouvelle (FR)
- Université Paris Cité (FR)
- University Hospital of Bern (CH)
- Sorbonne Université (FR)
- Université Sorbonne Paris Nord (FR)
- Sorbonne Paris Cité (FR)
- Assistance Publique – Hôpitaux de Paris (FR)
- Hôpital Lariboisière (FR)
- Kaiser Permanente San Francisco Medical Center (US)
- Hôpital Avicenne (FR)
- Paris Cardiovascular Research Center (FR)
- Momentum Research (US)
- Université Paris 1 Panthéon-Sorbonne (FR)
- Henkel (Germany) (DE)
Publication Details
- Journal
- ESC Heart Failure
- Published
- 2026-03-14
- DOI
- https://doi.org/10.1093/eschf/xvag076
- Primary Topic
- Heart Failure Treatment and Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00